Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory

https://doi.org/10.1016/j.ejca.2013.09.002Get rights and content

Abstract

Background

Individual country- and cancer site-specific studies suggest that the age-adjusted incidence of many common cancers has increased in European populations over the past two decades. To quantify the extent of these trends and the recent burden of cancer, here we present a comprehensive overview of trends in population-based incidence of the five common cancers across Europe derived from a new web-based portal of the European cancer registries.

Methods

Data on incidence for cancers of the colon and rectum, prostate, breast, corpus uteri and stomach diagnosed from 1988 to 2008 were obtained from the European Cancer Observatory for cancer registries from 26 countries. Annual age-standardised incidence rates and average annual percentage changes were calculated.

Results

Incidence of four common cancers in eastern and central European countries (prostate, postmenopausal breast, corpus uteri and colorectum) started to approach levels in northern and western Europe, where rates were already high in the past but levelled off in some countries in recent years. Decreases in stomach cancer incidence were seen in all countries.

Discussion

Increasing trends in incidence of the most common cancers, except stomach cancer, are bad news to public health but can largely be explained by well-known changes in society in the past decades. Thus, current and future efforts in primary cancer prevention should not only remain focussed on the further reduction of smoking but engage in the long-term efforts to retain healthy lifestyles, especially avoiding excess weight through balanced diets and regular physical exercise.

Introduction

Cancer has emerged as a leading cause of morbidity and mortality in European populations [1]. This development has made population-based, accurate and near-term information on cancer occurrence extremely valuable in order to identify trends, and risk factors driving those trends. Such data are also the foundation for adequate and purposeful cancer prevention, which needs to be continuously adapted according to the best available scientific evidence and knowledge [2]. Several initiatives at the European level have led to the formation of a network of cancer registries, allowing for comparisons across countries that provide insights into the impact of different risk factors, detection methods and treatment practices on the variation in cancer incidence and survival [3], [74].

Smoking, dietary habits and reproductive factors have been identified as the main (modifiable) risk factors for cancer in populations in industrialised countries, with different magnitudes and implications across countries and regions [4], [5]. Parallels between changes in the prevalence of those risk factors in the past and cancer incidence today highlight and confirm associations known for years. While smoking prevalence is still increasing in women in some countries in southern and central Europe [6], [7], it has decreased in men in Europe since the 1960s, leading to declines in lung cancer incidence since the 1980s or 1990s, first in northern and western Europe and later in eastern and southern Europe [8], [74]. At least 3–6% of all cancers in Europe have been related to high body mass index (BMI) and currently observed increases in BMI across all European countries [9], [10]. Although the impact of these recent changes in risk factor prevalence will only be fully reflected in cancer burden in the next 20–30 years [11], monitoring current trends may enable us to anticipate future increases in cancer burden.

Progress in cancer control has recently been measured using trends in incidence, mortality and survival based on data from 21 European cancer registries [12]. While improvements in early detection as well as treatment options have translated into an ongoing increase in survival and decrease in mortality, cancer prevention efforts have so far yielded only moderate successes. In this study, we aim to describe recent trends in incidence of the most common cancers in Europe in the past two decades, complementing the study of [74] on trends in incidence of smoking-related cancers. Population-based incidence data from cancer registries in 26 countries from the European Cancer Observatory [13] and Cancer Incidence in Five Continents (CI5) [14] were used to assess trends across European regions, age groups and sex. Where possible, incidence trends were assessed in the light of the changing prevalence of several known risk factors in European populations. This approach will shed light on the potential for improvement in cancer prevention.

Section snippets

Methods

Cancer incidence data by age and sex and corresponding population figures were obtained from the EUREG database (http://eu-cancer.iarc.fr/EUREG/Default.aspx), which has been developed in the framework of the EUROCOURSE project and is part of the European Cancer Observatory (ECO) website [13]. Annual country- and sex-specific age-standardised incidence rates (ASR), using the European Standard population, were calculated for 26 European countries between 1988 and 2008. Average annual percentage

Results and discussion

Trends in incidence of five major cancers in Europe since 1988 are presented by sex and region in Fig. 1, Fig. 2, Fig. 3, Fig. 4, Fig. 5, Fig. 6, Fig. 7, Fig. 8, Fig. 9, Fig. 10. Table 1 lists the corresponding absolute numbers of cancer cases at the beginning and at the end of the study period. The AAPC plotted against the incidence in the most recent year are displayed by cancer site and sex in Fig. 11, Fig. 12, Fig. 13, Fig. 14, Fig. 15, Fig. 16, Fig. 17, Fig. 18, Fig. 19, Fig. 20 and by sex

Conclusion

Increasing trends in incidence of the most common cancers in Europe are of concern, in particular those at younger ages, as observed for colorectal cancer in some central and eastern European countries, where incidence is high and still continues to increase. Although incidence rates have decreased for some cancers in some countries, e.g. corpus uteri cancer in western Europe, the absolute number of cases remained relatively stable (or even increased) during the study period due to ageing of

Authors’ contributions

M.A. contributed to study design, data analysis, data interpretation and wrote the first draft of the manuscript. H.K.K., J.W.C., G.B., A.A., J.F., A.R., D.F. and I.S. contributed to data interpretation, writing and reviewing the manuscript. I.S. additionally contributed to study design and supervised the study.

Role of the funding source

The sponsor of the study had no role in study design, data collection, data analysis or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.

Conflict of interest statement

None declared.

Acknowledgements

M.A. is supported by the World Cancer Research Fund, Grant number SG 2012/619. I.S. is funded through the Marie Curie Action Intra-European Fellowship, contract number 302050. EUROCOURSE (EUROpe against Cancer: Optimisation of the Use of Registries for Scientific Excellence in research), an EC 7th Framework Programme of DG Research and Innovation under Grant agreement number LSSH-CT-2008-219453 provided logistic support and time of J.W.C. through Workpackage 8. We thank Joannie Lortet-Tieulent

References (74)

  • V. Bagnardi et al.

    Light alcohol drinking and cancer: a meta-analysis

    Ann Oncol

    (2013)
  • D. Boll et al.

    Increased incidence and improved survival in endometrioid endometrial cancer diagnosed since 1989 in The Netherlands: a population based study

    Eur J Obstet Gynecol Reprod Biol

    (2013)
  • D. Forman et al.

    Gastric cancer: global pattern of the disease and an overview of environmental risk factors

    Best Pract Res Clin Gastroenterol

    (2006)
  • C. de Martel et al.

    Gastric cancer: epidemiology and risk factors

    Gastroenterol Clin North Am

    (2013)
  • M. Malvezzi et al.

    European cancer mortality predictions for the year 2013

    Ann Oncol

    (2013)
  • C. La Vecchia et al.

    Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975

    Ann Oncol

    (2010)
  • I. Soerjomataram et al.

    Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions

    Lancet

    (2012)
  • J.W. Coebergh et al.

    The long road towards cancer prevention: 4 steps backward and 8 forward

    Eur J Cancer

    (2010)
  • D.M. Parkin

    Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy?

    Eur J Cancer

    (2009)
  • M. Kumle

    Declining breast cancer incidence and decreased HRT use

    Lancet

    (2008)
  • J. Lortet-Tieulent et al.

    Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988–2010

    Eur J Cancer

    (2015)
  • The global burden of disease: 2004 update

    (2004)
  • D.M. Parkin

    The evolution of the population-based cancer registry

    Nat Rev Cancer

    (2006)
  • I. Soerjomataram et al.

    Excess of cancers in Europe: a study of eleven major cancers amenable to lifestyle change

    Int J Cancer

    (2007)
  • A. Gilmore et al.

    Prevalence of smoking in 8 countries of the former Soviet Union: results from the living conditions, lifestyles and health study

    Am J Public Health

    (2004)
  • WHO. Mean body mass index (BMI): situation and trends. In: Global health observatory (GHO);...
  • A.G. Renehan et al.

    Incident cancer burden attributable to excess body mass index in 30 European countries

    Int J Cancer

    (2010)
  • Steliarova-Foucher E, O’Callaghan M, Ferlay J, Masuyer E, Forman D, Comber H, et al. European cancer observatory:...
  • M.P. Curado et al.
    (2007)
  • F. Thomas et al.

    International variability of ages at menarche and menopause: patterns and main determinants

    Hum Biol

    (2001)
  • L. Giordano et al.

    Mammographic screening programmes in Europe: organization, coverage and participation

    J Med Screen

    (2012)
  • American Institute for Cancer Research, World Cancer Research Fund. Continuous update project report. Food, nutrition,...
  • Collaborative Group on Hormonal Factors in Breast Cancer, Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

    Lancet Oncol

    (2012)
  • P.H. Lahmann et al.

    Physical activity and breast cancer risk: the European prospective investigation into cancer and nutrition

    Cancer Epidemiol Biomark Prev

    (2007)
  • S. Shantakumar et al.

    Reproductive factors and breast cancer risk among older women

    Breast Cancer Res Treat

    (2007)
  • Collaborative Group on Hormonal Factors in Breast Cancer, Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease

    Lancet

    (2002)
  • P. Stattin et al.

    Non-systematic screening for prostate cancer in Sweden – survey from the National Prostate Cancer Registry

    Scand J Urol Nephrol

    (2003)
  • Cited by (395)

    • The use of tumor markers in prognosis of cancer and strategies to prevent cancer predisposition and progress

      2023, Biomarkers in Cancer Detection and Monitoring of Therapeutics: Discovery and Technologies: Volume 1
    View all citing articles on Scopus
    View full text